Clinical Trial: Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596992) titled 'Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.' on May 12.

Brief Summary: The aim of this project is to evaluate the effect of bioactive compound sources, propolis and royal jelly, on metabolomics, inflammation, and cardiovascular risk markers in participants with coronary artery disease. A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.

Study Start Date: May 18

Study Type: INTERVENTIONAL

Condition: Coronary Artery Disease (CAD) Oxidative Stress Inflammation

Intervent...